Technology News and Research

RSS

Bend Research signs collaboration agreement with Vertex Pharmaceuticals

Bend Research Inc., a company with more than 30 years of experience in applying innovative pharmaceutical technologies to help clients solve their most difficult scientific and technical problems, announced today that it has entered into a collaboration with Vertex Pharmaceuticals Incorporated, a global biotechnology company headquartered in Cambridge, MA.

9 Nov 2009

New, user-friendly web site unveiled by A-Life Medical

A-Life Medical, Inc., the pioneer and leading provider of computer-assisted coding (CAC) products and services to the healthcare industry, announced today that it has unveiled its new Web site at www.alifemedical.com.

9 Nov 2009

Olympus Medical Systems and Opitz + Flierl Hospitaltechnik offer complete integrated solutions for operating theatres

Under the leadership of its Systems Integration business unit, Olympus Medical Systems Europa GmbH, Hamburg, together with Opitz + Flierl Hospitaltechnik AG, Heideck near Nuremberg, Germany, have agreed a joint venture to meet the technological challenges of constructing hospital interiors for the future, whilst expanding their positions in the market.

From Evident Corporation - Life Sciences 9 Nov 2009

Researchers develop tools to visualize how different cell populations of cells communicate

Using imaging mass spectrometry, researchers at the University of California, San Diego have developed tools that will enable scientists to visualize how different cell populations of cells communicate. Their study shows how bacteria talk to one another - an understanding that may lead to new therapeutic discoveries for diseases ranging from cancer to diabetes and allergies.

9 Nov 2009

Sonova Holding enters into a share purchase agreement with shareholders of Advanced Bionics

Sonova Holding AG, the world's leading provider of hearing systems, announced today that it has entered into a share purchase agreement with the shareholders of Advanced Bionics Corporation, Los Angeles, USA.

9 Nov 2009

Symposium on non invasive diagnosis and management of hepatic fibrosis sponsored by Echosens

Echosens, the French high-technology company specializing in non-invasive diagnostics in hepatology is the official sponsor of the Symposium held by Pr Sarin in the Famous Institute of liver and Biliary Sciences of New Delhi today. This symposium will focus on the non invasive diagnosis and management of hepatic fibrosis, with speakers from all around the world.

9 Nov 2009

Research projects in the areas of mathematics and biochemistry score top marks

Research projects in the areas of mathematics and biochemistry scored top marks this evening, as Tim Kunisky of Livingston, NJ and the team of Benjamin Song and Quan (Jack) Chen of Audubon, PA received the highest honors at the Region Five Finals of the 2009 Siemens Competition in Math, Science & Technology, the nation's premier high school science competition.

9 Nov 2009

TNS files Provisional Use Patent application on the ability of a natural organic mushroom formula

Total Nutraceutical Solutions, Inc. (TNS), announced that it has filed a Provisional Use Patent application on the ability of a proprietary natural organic mushroom formula to control oxidative stress.

9 Nov 2009

Verizon director to address challenges facing the health care industry in complying to HITECH and HIPAA

An executive from the Verizon Connected Healthcare Solutions practice group will participate in a panel discussion at the World Health Congress Leadership Summit on Health Information Technology on Nov. 9 in Alexandria.

7 Nov 2009

Demand for products and services by life science industry is expected to grow rapidly

We Work for Health, an alliance of Washington state business, academic, government and community leaders, today released the results of a first-of-its-kind economic impact study showing that employment in Washington's life sciences sector has passed many of the traditional resource-based industries on which the state's economy was founded, and is in the same range of importance as some of the new, technology-based industries of the state.

7 Nov 2009

Experts gather to outline the latest creative applications of DNA barcoding

The scientific ability to quickly and accurately identify species through DNA "barcoding" is being embraced and applied by a growing legion of global authorities - from medical and agricultural researchers to police and customs authorities to palaeontologists and others.

7 Nov 2009

Locus Pharmaceuticals creates a new division, Ansaris

Locus Pharmaceuticals, a drug company that has developed its own internal and partnered pipeline, focusing on oncology, immunology, and inflammatory targets, today announced that in conjunction with a transformation to a drug discovery collaboration business model, it has created a new division, Ansaris, which will include most of its operations and personnel.

7 Nov 2009

FDA's approval time for medical devices increases

According to MassDevice.com, the online business journal of the medical device industry, medical device approval times under the Food & Drug Administration's 510(k) clearance process jumped 30 percent between 2005 and 2008. MassDevice's exclusive investigation of 10 years of FDA data, Eye on the FDA: H1 2009, shows that approval times for medical devices increased nearly 2 percent — while the number of 510(k) applications declined more than 19 percent — even as the FDA's budgets and staff levels rose.

7 Nov 2009

Health care leaders to address the value of collaboration and challenges inherent to interoperability

A panel of executives representing public-sector health, health care providers, health care information technology, and health plans will address the value of collaboration and the challenges inherent to interoperability, especially as both topics pertain to health information networks.

7 Nov 2009

Halozyme Therapeutics announces results of its insulin variability study

Halozyme Therapeutics, Inc. today announced insulin variability study results that demonstrated reduced intrasubject absorption variability for the combination of lispro, a meal time analog insulin, plus PH20 (hyaluronidase) compared to subcutaneous injection of lispro alone.

7 Nov 2009

Roper Industries to acquire Verathon

Roper Industries, Inc. (NYSE: ROP) today announced that it has signed a definitive agreement to acquire Verathon, Inc., a leading provider of proprietary medical devices. The Verathon Board of Directors has approved the transaction and the closing is subject to customary regulatory approvals and closing conditions, including shareholder approval. The parties expect the closing to be completed in early December.

7 Nov 2009

Health policy research roundup

Health Affairs: Enrollment Is Driving Medicaid Costs—But Two Targets Can Yield Savings - "Although Medicaid spending has grown faster than the rate of increase in national health spending, much of this is explained by increased enrollment," write the authors of this paper, who present data showing that "[p]er enrollee, Medicaid spending actually compares favorably to increases in medical care prices and gross domestic product."

7 Nov 2009

Nytimes looks at doctors' crucial role in reshaping U.S. health system

Doctors and hospital payment systems remain at the center of the health care reform debate as news outlets examine the benefits of replacing the current fee-for-service approach.

7 Nov 2009

Increased use of CAS procedures to treat carotid stenosis associated with adverse clinical outcomes

Among eligible Medicare beneficiaries, increased use of carotid arterial stenting (CAS) procedures to treat carotid stenosis-the narrowing of the carotid artery-is associated with higher rates of mortality and adverse clinical outcomes, including heart attack and stroke, according to researchers from the University of Pennsylvania School of Medicine.

7 Nov 2009

NIH grants $1 million to study whether Transcendental Meditation can prevent future heart attacks in CHD patients

The National Institutes of Health's National Heart, Lung, and Blood Institute will fund a $1 million collaborative study by the Center for Natural Medicine and Prevention at Maharishi University of Management Research Institute and Columbia University Medical Center to determine whether the stress-reducing Transcendental Meditation technique can help patients with coronary heart disease (CHD) prevent future heart attacks, strokes and death.

7 Nov 2009

Technology News and Research

Bend Research signs collaboration agreement with Vertex Pharmaceuticals

New, user-friendly web site unveiled by A-Life Medical

Olympus Medical Systems and Opitz + Flierl Hospitaltechnik offer complete integrated solutions for operating theatres

Researchers develop tools to visualize how different cell populations of cells communicate

Sonova Holding enters into a share purchase agreement with shareholders of Advanced Bionics

Symposium on non invasive diagnosis and management of hepatic fibrosis sponsored by Echosens

Research projects in the areas of mathematics and biochemistry score top marks

TNS files Provisional Use Patent application on the ability of a natural organic mushroom formula

Verizon director to address challenges facing the health care industry in complying to HITECH and HIPAA

Demand for products and services by life science industry is expected to grow rapidly

Experts gather to outline the latest creative applications of DNA barcoding

Locus Pharmaceuticals creates a new division, Ansaris

FDA's approval time for medical devices increases

Health care leaders to address the value of collaboration and challenges inherent to interoperability

Halozyme Therapeutics announces results of its insulin variability study

Roper Industries to acquire Verathon

Health policy research roundup

Nytimes looks at doctors' crucial role in reshaping U.S. health system

Increased use of CAS procedures to treat carotid stenosis associated with adverse clinical outcomes

NIH grants $1 million to study whether Transcendental Meditation can prevent future heart attacks in CHD patients

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

Latest News